ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0779
0.00%
Brent Oil
72.72
0.00%
Bitcoin
97,772.13
0.01%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Opko Health Inc (OPK)

  7. Opko Health Inc (OPK) Noticias

OPK

Opko Health (OPK)

Opko Health Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:OPK
FechaHoraFuenteTítuloSímboloCompañía
10/12/202407:00PR Newswire (US)NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online RetailerNASDAQ:OPKOpko Health Inc
20/11/202420:36Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:OPKOpko Health Inc
20/11/202407:00GlobeNewswire Inc.OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:OPKOpko Health Inc
18/11/202407:00PR Newswire (US)NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoNASDAQ:OPKOpko Health Inc
14/11/202405:00PR Newswire (US)NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 ResultsNASDAQ:OPKOpko Health Inc
13/11/202415:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:OPKOpko Health Inc
08/11/202415:05GlobeNewswire Inc.Entera Bio Reports Q3 2024 Financial Results and Provides Business UpdatesNASDAQ:OPKOpko Health Inc
07/11/202415:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
07/11/202415:05GlobeNewswire Inc.OPKO Health Reports Third Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
07/11/202407:00GlobeNewswire Inc.Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®NASDAQ:OPKOpko Health Inc
29/10/202415:05GlobeNewswire Inc.OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:OPKOpko Health Inc
07/10/202407:00PR Newswire (US)NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into JapanNASDAQ:OPKOpko Health Inc
07/10/202407:00GlobeNewswire Inc.ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza ProgramNASDAQ:OPKOpko Health Inc
25/09/202407:30GlobeNewswire Inc.Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic DisordersNASDAQ:OPKOpko Health Inc
23/09/202407:00GlobeNewswire Inc.OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical DevelopmentNASDAQ:OPKOpko Health Inc
20/09/202413:56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPKOpko Health Inc
16/09/202406:30PR Newswire (US)Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthNASDAQ:OPKOpko Health Inc
30/08/202416:01Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:OPKOpko Health Inc
19/08/202416:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
09/08/202415:05GlobeNewswire Inc.Entera Bio Reports Q2 2024 Financial Results and Provides Business UpdatesNASDAQ:OPKOpko Health Inc
07/08/202415:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPKOpko Health Inc
07/08/202415:06GlobeNewswire Inc.OPKO Health Reports Second Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
01/08/202415:05GlobeNewswire Inc.OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024NASDAQ:OPKOpko Health Inc
18/07/202407:00GlobeNewswire Inc.OPKO Health Announces $100 Million Share Repurchase ProgramNASDAQ:OPKOpko Health Inc
17/07/202415:14GlobeNewswire Inc.OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share PaymentsNASDAQ:OPKOpko Health Inc
02/07/202407:00PR Newswire (US)NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing PartnerNASDAQ:OPKOpko Health Inc
31/05/202409:48GlobeNewswire Inc.OPKO Health to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OPKOpko Health Inc
07/05/202415:05GlobeNewswire Inc.OPKO Health Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
03/05/202407:00GlobeNewswire Inc.OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:OPKOpko Health Inc
28/03/202407:00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNASDAQ:OPKOpko Health Inc
 Showing the most relevant articles for your search:NASDAQ:OPK

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
NYSE
XOM
Exxon Mobil
COIN
ADAUSD
Cardano
USOTC
ADDYY
Adidas (QX)
USOTC
RHHBY
Roche (QX)
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
CCOM
US30
US 30
COIN
SOLUSD
Solana
COIN
XRPUSD
Ripple
COIN
AVAXUSD
Avalanche
NASDAQ
AMZN
Amazon.com
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados